Shares of Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the fourteen analysts that are covering the company, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 1 […]
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Stock analysts at Leerink Partnrs decreased their FY2025 earnings estimates for Exact Sciences in a research report issued to clients and investors on Wednesday, August 2nd. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will post earnings per share of $0.83 for the […]
Exact Sciences (NASDAQ:EXAS – Free Report) had its target price raised by Credit Suisse Group from $75.00 to $90.00 in a research note issued to investors on Wednesday, Marketbeat.com reports. Credit Suisse Group currently has a neutral rating on the medical research company’s stock. Other analysts also recently issued reports about the stock. StockNews.com started […]
Recent Investment Analysts Ratings Updates for Exact Sciences (EXAS) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Victory Capital Management Inc. lifted its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 537.5% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 126,755 shares of the medical research company’s stock after acquiring an additional 106,872 shares during the period. […]